Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease

Objective: To define the impact of associated abnormalities on the efficacy of the novel subtropical guidelines for palivizumab prophylaxis on respiratory syncytial virus (RSV)-related hospitalizations in patients with hemodynamically significant congenital heart disease (hsCHD). Method: This prospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Shuenn-Nan, Wang, Ching-Chia, Lin, Ming-Tai, Chen, Chun-An, Lu, Chun-Wei, Hua, Yu-Chuan, Wu, Jing-Ming, Wu, Mei-Hwan, Wang, Jou-Kou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767946/
https://www.ncbi.nlm.nih.gov/pubmed/35071127
http://dx.doi.org/10.3389/fped.2021.756787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767946/
https://www.ncbi.nlm.nih.gov/pubmed/35071127
http://dx.doi.org/10.3389/fped.2021.756787

Ejemplares similares